120 related articles for article (PubMed ID: 35485310)
1. Polymorphism association of NIL1, NIL2, CYP1A1 xenobiotic metabolism genes and their expression with the risk of colorectal cancer in the Polish population.
Kabziński J; Gogolewska M; Nowakowski M; Kucharska E; Dziki Ł; Mik M; Dziki A; Majsterek I
Pol Przegl Chir; 2022 Mar; 94(2):54-59. PubMed ID: 35485310
[TBL] [Abstract][Full Text] [Related]
2. Association of GEMIN4 gene polymorphisms with the risk of colorectal cancer in the Polish population.
Cieślak A; Galita G; Mik M; Dziki Ł; Dziki A; Sokołowski I; Popławski T; Majsterek I
Pol Przegl Chir; 2021 Nov; 93(0):40-45. PubMed ID: 35384865
[TBL] [Abstract][Full Text] [Related]
3. Sequence Polymorphism in Xenobiotic Metabolising Genes in Iraqi Colorectal Cancer Patients.
Ibrahem SQ; Al-Dalawi ZT; Bahaaldin AS
Asian Pac J Cancer Prev; 2021 Apr; 22(4):1203-1210. PubMed ID: 33906313
[TBL] [Abstract][Full Text] [Related]
4. Colorectal Cancer: Is it Still a Disease of the Elderly?
Kędzia-Berut R; Berut M; Włodarczyk M; Włodarczyk J; Dziki Ł; Dziki A; Mik M
Pol Przegl Chir; 2023 Dec; 96(0):41-45. PubMed ID: 38348978
[TBL] [Abstract][Full Text] [Related]
5. Associations between CYP1A1 rs1048943 A > G and rs4646903 T > C genetic variations and colorectal cancer risk: Proof from 26 case-control studies.
Zhu X; Wang Z; He J; Wang W; Xue W; Wang Y; Zheng L; Zhu ML
Oncotarget; 2016 Aug; 7(32):51365-51374. PubMed ID: 27384991
[TBL] [Abstract][Full Text] [Related]
6. CYP1A1 Ile462Val polymorphism and colorectal cancer risk in Polish patients.
Gil J; Gaj P; Misiak B; Ostrowski J; Karpinski P; Jarczyńska A; Kielan W; Sasiadek MM
Med Oncol; 2014 Jul; 31(7):72. PubMed ID: 24939416
[TBL] [Abstract][Full Text] [Related]
7. Interactions between cigarette smoking and selected polymorphisms in xenobiotic metabolizing enzymes in risk for colorectal cancer: A case-only analysis.
Pande M; Amos CI; Eng C; Frazier ML
Mol Carcinog; 2010 Nov; 49(11):974-80. PubMed ID: 20886582
[TBL] [Abstract][Full Text] [Related]
8. Genetic variations in the xenobiotic-metabolizing enzymes CYP1A1, CYP1A2, CYP2C9, CYP2C19 and susceptibility to colorectal cancer among Turkish people.
Özhan G; Mutur M; Ercan G; Alpertunga B
Genet Test Mol Biomarkers; 2014 Apr; 18(4):223-8. PubMed ID: 24527758
[TBL] [Abstract][Full Text] [Related]
9. Health locus of control among patients operated on for colorectal cancer.
Darnikowska J; Jędrzejczak B; Dziki A; Mik M
Pol Przegl Chir; 2021 Oct; 93(0):1-6. PubMed ID: 35384857
[TBL] [Abstract][Full Text] [Related]
10. Malnutrition as an unfavorable prognostic factor after surgical treatment for metastatic colorectal cancer.
Skroński M; Olszewska N; Nyckowski P; Ukleja A; Lisowska J; Słodkowski M; Szczygieł B
Pol Przegl Chir; 2024 Mar; 96(3):1-8. PubMed ID: 38721641
[TBL] [Abstract][Full Text] [Related]
11. Polymorphisms of xenobiotic-metabolizing genes and colorectal cancer risk in patients with lynch syndrome: A retrospective cohort study in Taiwan.
Kamiza AB; You JF; Wang WC; Tang R; Chang CY; Chien HT; Lai CH; Chiu LL; Lo TP; Hung KY; Hsiung CA; Yeh CC
Environ Mol Mutagen; 2018 Jan; 59(1):69-78. PubMed ID: 28714190
[TBL] [Abstract][Full Text] [Related]
12. Genetic polymorphisms in xenobiotic clearance genes and their influence on disease expression in hereditary nonpolyposis colorectal cancer patients.
Talseth BA; Meldrum C; Suchy J; Kurzawski G; Lubinski J; Scott RJ
Cancer Epidemiol Biomarkers Prev; 2006 Nov; 15(11):2307-10. PubMed ID: 17119063
[TBL] [Abstract][Full Text] [Related]
13. Small-molecule inhibitors of the PERK-mediated Unfolded Protein Response signaling pathway in targeted therapy for colorectal cancer.
Rozpedek-Kaminska W; Piotrzkowska D; Galita G; Pytel D; Kucharska E; Dziki Ł; Dziki A; Majsterek I
Pol Przegl Chir; 2022 Mar; 94(6):17-25. PubMed ID: 36468513
[TBL] [Abstract][Full Text] [Related]
14. High expression of CD133 - stem cell marker for prediction of clinically agressive type of colorectal cancer.
Kostovski O; Antovic S; Trajkovski G; Kostovska I; Jovanovic R; Jankulovski N
Pol Przegl Chir; 2020 Apr; 92(3):9-14. PubMed ID: 32759397
[TBL] [Abstract][Full Text] [Related]
15. Risk of renal cell carcinoma and polymorphism in phase I xenobiotic metabolizing CYP1A1 and CYP2D6 enzymes.
Ahmad ST; Arjumand W; Seth A; Nafees S; Rashid S; Ali N; Hamiza OO; Sultana S
Urol Oncol; 2013 Oct; 31(7):1350-7. PubMed ID: 22281432
[TBL] [Abstract][Full Text] [Related]
16. Patient-reported health-related quality of life after colorectal surgery.
Kuzmanovska B; Kuzmanovski I; Jankulovski N; Kartalov A; Osmani B; Srceva M; Brzanov N; Gavrilovska-Brzanov A
Pol Przegl Chir; 2021 Nov; 94(4):20-26. PubMed ID: 36047356
[TBL] [Abstract][Full Text] [Related]
17. Polymorphisms of the xenobiotic-metabolizing enzymes CYP1A1 and NAT-2 in systemic sclerosis and lupus erythematosus.
von Schmiedeberg S; Fritsche E; Rönnau AC; Specker C; Golka K; Richter-Hintz D; Schuppe HC; Lehmann P; Ruzicka T; Esser C; Abel J; Gleichmann E
Adv Exp Med Biol; 1999; 455():147-52. PubMed ID: 10599336
[TBL] [Abstract][Full Text] [Related]
18. Do We Underestimate Colorectal Cancer Patients Under 50?
Benli S; Colak T; Türkmenoğlu MÖ; Sari H; Baysan C
Pol Przegl Chir; 2022 May; 95(1):13-19. PubMed ID: 36806160
[TBL] [Abstract][Full Text] [Related]
19. Genetic variation in genes for the xenobiotic-metabolizing enzymes CYP1A1, EPHX1, GSTM1, GSTT1, and GSTP1 and susceptibility to colorectal cancer in Lynch syndrome.
Pande M; Amos CI; Osterwisch DR; Chen J; Lynch PM; Broaddus R; Frazier ML
Cancer Epidemiol Biomarkers Prev; 2008 Sep; 17(9):2393-401. PubMed ID: 18768509
[TBL] [Abstract][Full Text] [Related]
20. Retrospective analysis of treatment, including access to breast reconstructions, of breast cancer patients - war refugees from Ukraine in Poland - the experience of a single tertiary care institution.
Wow T; Murawa D; Boguszewska-Byczkiewicz K; Burzyński J; Ryk A; Kolacinska A
Pol Przegl Chir; 2023 Mar; 95(6):20-23. PubMed ID: 38058164
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
